Kyverna Therapeutics, Inc. Common Stock (KYTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $300.94M
Last updated: Nov 17, 2026 at 4:15 PM ET
Kyverna Therapeutics, Inc. Common Stock (KYTX) Stock Chart
Kyverna Therapeutics, Inc. Common Stock (KYTX) has a latest price of $4.70 on Nov 17, 2026, 65.6% below its 52-week high of $13.67. Its price fell 31.7% over the past 12 months.
Price Chart
From Feb 2024 to Oct 2026, its highest month-end close was $27.17 in Feb 2024 and its lowest $1.93 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KYTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KYTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 47.0%, and over 6 months it fell 46.0%.
| Period | Change |
|---|---|
| 1 month | -19.4% |
| 3 months | -47.0% |
| 6 months | -46.0% |
| 12 months | -31.7% |
| 12 months, with dividends | -31.7% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.67 | -39.7% |
| 2025 | $9.40 | +151.3% |
Trading Range
The price is 22.7% below its 50-day average of $6.08 and 40.2% below its 200-day average of $7.85.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.70 | |
| 52-week high | $13.67 | -65.6% |
| 52-week low | $4.50 | +4.6% |
| 50-day average | $6.08 | -22.7% |
| 200-day average | $7.85 | -40.2% |
Price Risk
Over 3 years, its largest fall from a peak was 93.9%.
| Measure | Value |
|---|---|
| 1-year beta | 2.25 |
| Largest fall, 1 year | -59.0% |
| Largest fall, 3 years | -93.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KYTX
What is KYTX's 1-year price change?
Kyverna Therapeutics, Inc. Common Stock's price fell 31.7% over the past 12 months. With dividends included, the 12-month total return was -31.7%.
What is KYTX's 52-week high and low?
Kyverna Therapeutics, Inc. Common Stock's 52-week high is $13.67 and its 52-week low is $4.50. Its latest price of $4.70 on Nov 17, 2026 is 65.6% below the high.
What is KYTX's beta?
Kyverna Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 2.25, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.0%.
Is the KYTX chart free?
Yes. Advanced Charting for KYTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KYTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors